Treatment for ROP in an Infant with Adenoviral Conjunctiviti
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Introduction
Retinopathy of prematurity (ROP) has been a leading cause of childhood blindness in developed and developing countries worldwide. LPC, and, later on, intravitreal bevacizumab injection (IVB) were administered for the treatment of the disease. Although LPC was the mainstay treatment option for most of ROP cases, IVB therapy has provided us with an alternative modality of treatment.
Adenoviral conjunctivitis (AVC), an acute ocular infection, includes findings such as photophobia, conjunctival injection, and excessive lacrimation. The common form of AVC is epidemic keratoconjunctivitis which is responsible for several outbreaks among adult and pediatric population. Various studies reported outbreaks due to adenovirus infections at neonatal intensive care unit (NICU). Also the association between AVC and ROP examinations has been previously published.
Our aim in this study was to introduce our clinical approach in LPC for ROP in a premature neonate infected with AVC.

Case Report
An infant with gestational age (GA) of 32 weeks and birth weight (BW) of 1440?g was firstly examined on postnatal 36 weeks for routine ROP screening in NICU of Zeynep Kamil Maternity and Children's Diseases Training and Research Hospital. Stage 1 zone II ROP without plus disease was noted in both eyes on fundus examination according to the International Classification of Retinopathy of Prematurity (ICROP) at first visit....


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383521/#!po=25.0000
Preview
Like
Comment
Share